Drug intelligence / Profile preview

n-linoleoylethanolamine

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

**n-linoleoylethanolamine** is a naturally occurring fatty acid ethanolamide and a member of the N-acylethanolamines class (NAEs), structurally defined as the ethanolamide of linoleic acid. It is found endogenously in animal tissues and in certain foods. It is considered to exhibit **endocannabinoid-like activity**, although it has only weak affinity for the canonical cannabinoid receptors (CB1 and CB2) and does not produce typical psychotropic cannabinoid effects. Instead, it is thought to exert biological effects mainly by **inhibiting fatty acid amide hydrolase (FAAH)**, leading to increased levels of other endocannabinoids such as anandamide, which in turn may potentiate anti-inflammatory and analgesic effects, including inhibition of NF-κB signaling. Animal studies suggest a role in metabolic regulation, such as reducing weight gain and circulating lipids, and decreasing inflammatory cytokines. It is under consideration primarily as a research tool and a potential dietary supplement for anti-inflammatory and metabolic applications[1][3][5][7].

Other names
linoleoylethanolamidelinoleoyl ethanolamidelinoleic ethanolamidelinoleoyl monoethanolamideN-(2-hydroxyethyl)octadeca-9,12-dienamideLinoleamide MEALEA
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on n-linoleoylethanolamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-linoleoylethanolamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call